Opioids for Agitation in Advanced Alzheimer’s Disease
نویسندگان
چکیده
We describe a patient with advanced young-onset Alzheimer’s disease whose intractable behavioral disturbance and agitation responded to short acting opioid medications after failure of multiple other medications and nonpharmacological methods of treatment. Opioids are a little explored but potentially useful addition to the armamentarium of tools for managing severe agitation in patients with dementia.
منابع مشابه
Effect of Head and Face Massage on Agitation in Elderly Alzheimer's Disease Patients
Background: Management of agitation in Alzheimer's patients with non-invasive treatment methods, such as massage therapy, is of paramount importance. Aim: This study was conducted to determine the effects of head and face massage on agitation in elderly Alzheimer’s patients living in nursing homes in Yazd, Iran. Method: This randomized controlled clinical trial was conducted on two groups (n=35...
متن کاملExtracellular Vesicles as Neprilysin Delivery Syemory Improvement of Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative brain disorder which has no effective treatment yet due to the blood barrier in the brain that limits the drugs with the potential of disease improvement. Extracellular vesicles (EVs) are biocompatible nanoparticles with a lipid membrane. These vesicles are secreted from various cells such as mesenchymal stem cells (MSCs) and can pass through biol...
متن کاملOpioid treatment for agitation in patients with advanced dementia.
BACKGROUND Some patients with advanced dementia cannot convey the experience of pain verbally and may react to pain with aggressive and agitated behaviors. We hypothesized that unrecognized pain could contribute to agitation and that low dose opioid therapy might reduce agitation by reducing pain. We therefore attempted to determine the effect of opioids on agitation in demented patients. MET...
متن کاملExtracellular Vesicles as Neprilysin Delivery Syemory Improvement of Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative brain disorder which has no effective treatment yet due to the blood barrier in the brain that limits the drugs with the potential of disease improvement. Extracellular vesicles (EVs) are biocompatible nanoparticles with a lipid membrane. These vesicles are secreted from various cells such as mesenchymal stem cells (MSCs) and can pass through biol...
متن کاملMaintaining Patients With Alzheimer’s Disease in the Home Environment
he prevalence of Alzheimer’s disease (AD) continues to increase as the general population ages. The number of persons with AD is predicted to reach 13.2 million by 2050. With the baby boom generation entering the age of increasing risk, even more families will find themselves caring for a loved one with AD over the next decade. Family members or friends typically become caregivers while the aff...
متن کامل